Author

Jonathan David Berkman

Observed name: Jonathan Berkman

Institution: VCU Massey Comprehensive Cancer Center

Observed institutions: Albert Einstein College of Medicine, Virginia Commonwealth University, Montefiore Einstein Comprehensive Cancer Center, VCU Massey Comprehensive Cancer Center, University of Nebraska Medical Center, Virginia Commonwealth University Medical Center

ORCID: 0000-0001-8155-394X

Observed ORCID: 0000-0001-8155-394X

OpenAlex ID: A5044828199

Targeted therapies in non-small cell lung cancer: present and future

2023 · Jessica McLaughlin, Jonathan Berkman, et al. · Faculty Reviews · 23

Comparative analysis of pembrolizumab and cetuximab-based therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma: Real-world data.

2024 · Zahra Hamedi, Andrea Yachee Lo, et al. · Journal of Clinical Oncology · 2

Abstract 5970: Differences in survival outcomes based on timing and location of initial systemic therapy in patients with extensive stage small cell lung cancer

2025 · Andrea Y. Lo, Zahra Hamedi, et al. · Cancer Research

Characterization of DNA damage repair (DDR) alterations and the tumor immune microenvironment (TIME) in advanced non-small cell lung cancer (NSCLC).

2024 · Kamya Sankar, Jacob Mercer, et al. · Journal of Clinical Oncology

Works count: 4

Citation count: 25

H-index: 2

I10-index: 1